Methods and techniques for identifying the authenticity of mirikizumab

Milikizumab (Mirikizumab) is a humanized IgG4 monoclonal antibody that is an interleukin-23 (IL-23) antagonist. It specifically binds to the p19 subunit of IL-23 and blocks its binding to the receptor, thereby regulating intestinal and systemic inflammatory responses. Clinical data shows that it can improve the symptoms of patients with moderate to severe active inflammatory bowel disease, including ulcerative colitis (UC) and Crohn's disease (CD), by reducing symptoms such as diarrhea, bloody stools, and abdominal pain, and improving quality of life. At the same time, its subcutaneous injection method and relatively fixed dosing interval make it more convenient for patients to self-manage at home and reduce the medical burden of long-term intravenous infusion.

1) Purchase through formal channels: Patients should choose hospitals, pharmacies or officially designated overseas drug purchase channels with legal qualifications, and avoid obtaining through informal networks or personal purchasing.

2) Packaging and label verification: Genuine drug packaging usually has batch number, expiration date, manufacturer information and unique anti-counterfeiting marks. The outer packaging printing is clear, without typos, and the color is uniform, which is an important basis for judgment.

3) Drug appearance identification: The genuine product is a sterile, clear to light milky white solution, and is for one-time use only. Any sedimentation, turbidity, or unusual color should raise alarm.

4) Consult a medical professional: Before use, you can ask a doctor or pharmacist to help confirm the authenticity of the drug and instruct patients to store and use it correctly.

5) Anti-counterfeiting QR code or traceability system: Some original drugs provide batch and expiry date scanning services, and the authenticity can be verified through the official website.

Through the above measures, we can effectively ensure the safety of medication, avoid the risks caused by counterfeit drugs, and help patients correctly evaluate the true efficacy of militizumab.

Keyword tags: Mirikizumab benefits,Mirikizumab, IL-23 antagonist, inflammatory bowel disease medication, authenticity identification, medication safety, ulcerative colitis treatment, Crohn's disease management

Reference materials:https://en.wikipedia.org/wiki/Mirikizumab